Head of JLABS @ Washington, DC
As Head of JLABS @ Washington, DC, Sally sets the strategic direction and oversees all operational activities for JLABS in the greater Washington metro region, including Maryland and Virginia. In addition to managing the business of JLABS, Sally is responsible for the process of evaluating, selecting and accelerating a strong portfolio of innovators for JLABS @ Washington, DC. Sally joined JLABS after serving as a senior director, strategy & operations on the Global External Innovation team at Johnson & Johnson, where she drove global external portfolio management and reporting, while leading cross-sector engagement, as well as supporting strategic business plan development.
Sally began her research career at a San Diego-based biotech start-up, moving from bioinformatics into project management, and supported the subsequent acquisition and integration by Centocor, a Johnson & Johnson company. Following integration, Sally held research operations and strategic planning positions supporting the portfolio for antibody R&D at Johnson & Johnson. Sally left Johnson & Johnson for an international position with ITI Life Sciences, a UK governmental economic development agency aimed at developing innovative early-stage biotech and academic collaborative programs. There she developed partnership and commercialization plans for age-related macular degeneration disease solutions and stem cell technologies.
After ITI, Sally rejoined Johnson & Johnson at Janssen Pharmaceuticals, building a research operations & alliance management team within Immunology to support an early development portfolio, which was fifty percent externally and globally partnered. Her experience within Janssen includes both discovery research and early clinical portfolios, strategic initiatives in translational medicine, the development of partnerships with the Johnson & Johnson Innovation Centers and driving teams to enhance a positive corporate culture.
Sally received her MBA from the University of California Berkeley, Haas School of Business, and was recognized by Poets and Quants as one of the “Top 50” EMBA students across US & International Executive Programs in 2016. She also holds an MSc. in Microbiology / Immunology and an undergraduate degree in Biology from Virginia Tech.
With a passion for Johnson & Johnson’s Diversity & Inclusion work, Sally has also helped shape and lead the WiSTEM2D (Women in Science Technology Engineering Math Manufacturing & Design) Scholars Program, a global Johnson & Johnson initiative designed to inspire girls and young women to pursue studies and careers in STEM2D fields.